Log in

NYSEARCA:GNOM - Global X Genomics & Biotechnology ETF Stock Price, Forecast & News

$12.01
-0.45 (-3.61 %)
(As of 04/2/2020 05:24 AM ET)
Add
Today's Range
$12.01
Now: $12.01
$12.51
50-Day Range
$10.57
MA: $13.79
$16.03
52-Week Range
$10.16
Now: $12.01
$16.45
Volume15,900 shs
Average Volume10,176 shs
Market Capitalization$16.81 million
P/E RatioN/A
Dividend Yield0.00%
BetaN/A

Basic Details

Issuer Global X
Fund NameGlobal X Genomics & Biotechnology ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:GNOM
Inception Date4/5/2019
Fund ManagerChang Kim, James Ong, Nam To, Wayne Xie
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkSolactive Genomics Index
CategoryStrategy
FocusTheme
Development LevelBlended Development
RegionGlobal

Fund Statistics

Assets Under Management$17.69 million
Average Daily Volume$10,447.00
Discount/Premium1.37%

ETF Expenses

Management Fee0.68%
Other Expenses0.00%
Total Expenses0.68%
Fee Waiver0.00%
Net Expenses0.68%

Administrator, Advisor and Custodian

AdministratorGlobal X Management Company LLC
AdvisorGlobal X Management Company LLC
CustodianBrown Brothers Harriman & Co.
DistributorSEI Investments Distribution Co.
Transfer AgentBrown Brothers Harriman & Co.
Trustee
Lead Market Maker

Receive GNOM News and Ratings via Email

Sign-up to receive the latest news and ratings for GNOM and its competitors with MarketBeat's FREE daily newsletter.


Geographic Exposure of Global X Genomics & Biotechnology ETF (NYSEARCA:GNOM)
Currency Exposure of Global X Genomics & Biotechnology ETF (NYSEARCA:GNOM)
Sector Exposure of Global X Genomics & Biotechnology ETF (NYSEARCA:GNOM)
Industry Exposure of Global X Genomics & Biotechnology ETF (NYSEARCA:GNOM)

Global X Genomics & Biotechnology ETF (NYSEARCA:GNOM) Frequently Asked Questions

How has Global X Genomics & Biotechnology ETF's stock been impacted by COVID-19 (Coronavirus)?

Global X Genomics & Biotechnology ETF's stock was trading at $12.96 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, GNOM shares have decreased by 7.3% and is now trading at $12.01. View which stocks have been mosted impacted by Coronavirus.

Has Global X Genomics & Biotechnology ETF been receiving favorable news coverage?

News articles about GNOM stock have trended very negative recently, according to InfoTrie Sentiment. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Global X Genomics & Biotechnology ETF earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutGlobal X Genomics & Biotechnology ETF.

What other stocks do shareholders of Global X Genomics & Biotechnology ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global X Genomics & Biotechnology ETF investors own include AT&T (T), Energy Recovery (ERII) and Enphase Energy (ENPH).

What is Global X Genomics & Biotechnology ETF's stock symbol?

Global X Genomics & Biotechnology ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "GNOM."

How do I buy shares of Global X Genomics & Biotechnology ETF?

Shares of GNOM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Global X Genomics & Biotechnology ETF's stock price today?

One share of GNOM stock can currently be purchased for approximately $12.01.

How big of a company is Global X Genomics & Biotechnology ETF?

Global X Genomics & Biotechnology ETF has a market capitalization of $16.81 million.  View additional information about Global X Genomics & Biotechnology ETF.


MarketBeat Community Rating for Global X Genomics & Biotechnology ETF (NYSEARCA GNOM)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  4 (Vote Outperform)
Underperform Votes:  2 (Vote Underperform)
Total Votes:  6
MarketBeat's community ratings are surveys of what our community members think about Global X Genomics & Biotechnology ETF and other stocks. Vote "Outperform" if you believe GNOM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GNOM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel